Login / Signup

Heparin and Derivatives for Advanced Cell Therapies.

Sandra Laner-PlambergerMichaela OellerEva RohdeKatharina SchallmoserDirk Strunk
Published in: International journal of molecular sciences (2021)
Heparin and its derivatives are saving thousands of human lives annually, by successfully preventing and treating thromboembolic events. Although the mode of action during anticoagulation is well studied, their influence on cell behavior is not fully understood as is the risk of bleeding and other side effects. New applications in regenerative medicine have evolved supporting production of cell-based therapeutics or as a substrate for creating functionalized matrices in biotechnology. The currently resurgent interest in heparins is related to the expected combined anti-inflammatory, anti-thrombotic and anti-viral action against COVID-19. Based on a concise summary of key biochemical and clinical data, this review summarizes the impact for manufacturing and application of cell therapeutics and highlights the need for discriminating the different heparins.
Keyphrases
  • single cell
  • cell therapy
  • sars cov
  • coronavirus disease
  • venous thromboembolism
  • endothelial cells
  • anti inflammatory
  • machine learning
  • mesenchymal stem cells
  • deep learning
  • high resolution
  • data analysis